Groundbreaking study reveals new single-chain mRNA vaccines provide 100% protection against lethal mpox challenge in mice, far outperforming traditional vaccines. Study: Single-chain A35R-M1R-B6R ...
A therapy based on messenger RNA (mRNA), a genetic material actively studied for vaccines and other applications, has turned ...
Zacks Investment Research on MSN
CHMP backs EU approval of MRNA's new COVID-19 vaccine mNexSpike
Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending the EU approval of mNexspike ...
Changing just one atom in a COVID-19 vaccine lipid redirects delivery from the liver to the spleen, improving tumor ...
A Stanford-led study probes why a very small number of people develop heart inflammation shortly after mRNA COVID-19 ...
Creative Biolabs optimizes the mRNA drug development model by integrating sequence design, RNA-protein interaction ...
The Stanford summary backs up the "rare" label with specific numbers: about one myocarditis case per 140,000 people after a ...
People are still debating whether the mRNA from COVID-19 vaccines remains in the body longer than it should. Some say it lingers and causes harm, others say that idea just doesn’t hold up. A new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback